Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 04-2006 | 04-2005 | 04-2004 | 04-2003 | 04-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 589 | 302 | 178 | 2,442 |
| Other current assets | 78 | 0 | 0 | 0 | 0 |
| TOTAL | $155 | $666 | $421 | $251 | $2,532 |
| Non-Current Assets | |||||
| PPE Net | 298 | 384 | 407 | 426 | 486 |
| Intangibles | 158 | 212 | 220 | 238 | 259 |
| TOTAL | $456 | $596 | $627 | $664 | $744 |
| Total Assets | $611 | $1,262 | $1,048 | $915 | $3,276 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 176 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 152 | 270 | 237 | 12 | 41 |
| Accrued Expenses | 82 | 44 | 56 | 2 | 32 |
| TOTAL | $425 | $314 | $294 | $15 | $179 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $425 | $314 | $294 | $15 | $179 |
| Shareholders' Equity | |||||
| Common Shares | 1,366 | 1,257 | 1,138 | 888 | 886 |
| Retained earnings | -27,689 | -23,623 | -20,950 | -18,701 | -16,473 |
| Other shareholders' equity | -16 | 31 | -143 | 0 | 0 |
| TOTAL | $186 | $948 | $754 | $900 | $3,097 |
| Total Liabilities And Equity | $611 | $1,262 | $1,048 | $915 | $3,276 |